Want to join the conversation?
Bob Brackett of Bernstein Research probes whether EOR is a producer-injector concept or a huff and puff. $EOG CEO Bill Thomas said the company is not ready to give a lot of specific details about how it is doing that or interaction between wells and those kinds of things.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?